117 related articles for article (PubMed ID: 3566189)
1. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U
Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189
[TBL] [Abstract][Full Text] [Related]
2. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251
[TBL] [Abstract][Full Text] [Related]
3. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S
Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304
[TBL] [Abstract][Full Text] [Related]
4. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
Brox LW; Gowans B; Belch A
Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
[TBL] [Abstract][Full Text] [Related]
5. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
Parsons PG; Carter FB; Morrison L; Regius Mary Sister
Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
[TBL] [Abstract][Full Text] [Related]
8. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U; Nilsson B
Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896
[TBL] [Abstract][Full Text] [Related]
9. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.
Hansson J; Berhane K; Castro VM; Jungnelius U; Mannervik B; Ringborg U
Cancer Res; 1991 Jan; 51(1):94-8. PubMed ID: 1988111
[TBL] [Abstract][Full Text] [Related]
11. Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio.
Lewensohn R; Hansson J; Ringborg U; Ehrsson H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):783-8. PubMed ID: 3653195
[TBL] [Abstract][Full Text] [Related]
12. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia.
Panasci L; Henderson D; Torres-Garcia SJ; Skalski V; Caplan S; Hutchinson M
Cancer Res; 1988 Apr; 48(7):1972-6. PubMed ID: 3349471
[TBL] [Abstract][Full Text] [Related]
13. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
Parsons PG
Cancer Res; 1984 Jul; 44(7):2773-8. PubMed ID: 6722805
[TBL] [Abstract][Full Text] [Related]
14. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
Richardson ME; Siemann DW
Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
[TBL] [Abstract][Full Text] [Related]
15. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
Lewensohn R; Ehrsson H; Hansson J; Ringborg U
Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366
[TBL] [Abstract][Full Text] [Related]
16. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro.
Ducore JM; McNamara L
Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230
[TBL] [Abstract][Full Text] [Related]
17. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
Souliotis VL; Dimopoulos MA; Sfikakis PP
Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
[TBL] [Abstract][Full Text] [Related]
18. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
Batist G; Torres-Garcia S; Demuys JM; Greene D; Lehnert S; Rochon M; Panasci L
Mol Pharmacol; 1989 Aug; 36(2):224-30. PubMed ID: 2770701
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a melphalan-resistant human multiple myeloma cell line.
Bellamy WT; Dalton WS; Gleason MC; Grogan TM; Trent JM
Cancer Res; 1991 Feb; 51(3):995-1002. PubMed ID: 1988143
[TBL] [Abstract][Full Text] [Related]
20. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
Chresta CM; Crook TR; Souhami RL
Cancer Res; 1990 Jul; 50(13):4067-71. PubMed ID: 2354456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
